N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells

por Feduska, Joseph M, Garcia, Patrick L, Brennan, Stephanie B, Bu, Su, Council, Leona N, Yoon, Karina J
Publicado 2013

Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma

por Garcia, Patrick L., Council, Leona N., Christein, John D., Arnoletti, J. Pablo, Heslin, Marty J., Gamblin, Tracy L., Richardson, Joseph H., Bjornsti, Mary-Ann, Yoon, Karina J.
Publicado 2013

The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors

por Miller, Aubrey L., Fehling, Samuel C., Garcia, Patrick L., Gamblin, Tracy L., Council, Leona N., van Waardenburg, Robert C.A.M., Yang, Eddy S., Bradner, James E., Yoon, Karina J.
Publicado 2019

The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

por Miller, Aubrey L., Garcia, Patrick L., Fehling, Samuel C., Gamblin, Tracy L., Vance, Rebecca B., Council, Leona N., Chen, Dongquan, Yang, Eddy S., van Waardenburg, Robert C. A. M., Yoon, Karina J.
Publicado 2021

Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors

por Miller, Aubrey L., Garcia, Patrick L., Pressey, Joseph G., Beierle, Elizabeth A., Kelly, David R., Crossman, David K., Council, Leona N., Daniel, Richard, Watts, Raymond G., Cramer, Stuart L., Yoon, Karina J.
Publicado 2017

Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study

por Cramer, Stuart L., Miller, Aubrey L., Pressey, Joseph G., Gamblin, Tracy L., Beierle, Elizabeth A., Kulbersh, Brian D., Garcia, Patrick L., Council, Leona N., Radhakrishnan, Rupa, Hendrix, Skyler V., Kelly, David R., Watts, Raymond G., Yoon, Karina J.
Publicado 2018